MARATTO

article · Current Topics in Medicinal Chemistry

Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential AnticancerAgents

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The hybrids were selective towards some cancer cells. However, further <i>in vivo</i> studies are needed to fully understand their mode of action.

Research topics

  • Cancer therapeutics and mechanisms
  • Antibiotics Pharmacokinetics and Efficacy
  • Synthesis and Biological Evaluation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2174/0115680266288319240206052223

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.